Skip to main content

Table 4 Laboratory and neuroimaging

From: Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a neuroradiological method to help differentiate from primary central nervous system vasculitis

Laboratory analysis  
ESR (mean ± standard deviation) (mm/h) 15/28 ± 8/14 (n = 4)
CRP abnormal (≥ 0.5 mg/dl), n (%) 2 (15.4)
Vasculitis parameters positive, n (%) 2 (25)
Abnormal CSF, n (%) 9 (81.8)  
 Cell count (mean; median; range) (cells/mm3) 10.3; 8.5; 1–29 (n = 10)
 Protein concentration (mean; median, range) (mg/l) 456.4; 429.5; 363–604 (n = 8)
 Oligoclonal bands positive, n (%) 3 (27.3)
Neuroimaging, n (%)  
Infarct 6 (46.2)
 Border zone infarct 2 (28.6)
 Territorial infarct 4 (57.1)
 Cerebellar infarct 1 (14.2)
Multiple infarcts 4 (30.8)
Microbleeds 1 (7.7)
Parenchymal hemorrhage 1 (7.7)
Subarachnoid hemorrhage 4 (30.8)
 Cortical localisation 3 (75)
Posterior reversible encephalopathy syndrome (PRES) 2 (15.4)
Abnormal CTA/MRA 6 (54.5)